| Literature DB >> 28013427 |
Bradley Sherborne1, Veerabahu Shanmugasundaram2, Alan C Cheng3, Clara D Christ4, Renee L DesJarlais5, Jose S Duca6, Richard A Lewis7, Deborah A Loughney8, Eric S Manas9, Georgia B McGaughey10, Catherine E Peishoff11, Herman van Vlijmen11.
Abstract
In May and August, 2016, several pharmaceutical companies convened to discuss and compare experiences with Free Energy Perturbation (FEP). This unusual synchronization of interest was prompted by Schrödinger's FEP+ implementation and offered the opportunity to share fresh studies with FEP and enable broader discussions on the topic. This article summarizes key conclusions of the meetings, including a path forward of actions for this group to aid the accelerated evaluation, application and development of free energy and related quantitative, structure-based design methods.Mesh:
Substances:
Year: 2016 PMID: 28013427 DOI: 10.1007/s10822-016-9996-y
Source DB: PubMed Journal: J Comput Aided Mol Des ISSN: 0920-654X Impact factor: 3.686